Shopping Cart
Remove All
Your shopping cart is currently empty
UDM-001651 is an effective and orally bioavailable protease-activated receptor 4 antagonists (IC50=4 nM; Kd=1.4 nM). UDM-001651 displays antiplatelet potency (IC50=25 nM) in a γ-thrombin-induced platelet-rich plasma aggregation assay.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,258 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,980 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $4,000 | 8-10 weeks | 8-10 weeks |
| Description | UDM-001651 is an effective and orally bioavailable protease-activated receptor 4 antagonists (IC50=4 nM; Kd=1.4 nM). UDM-001651 displays antiplatelet potency (IC50=25 nM) in a γ-thrombin-induced platelet-rich plasma aggregation assay. |
| Targets&IC50 | PAR4:(kd)1.4 nM, PAR4:4 nM |
| Molecular Weight | 513.56 |
| Formula | C28H23N3O5S |
| Cas No. | 1477497-01-0 |
| Smiles | O(CC1=CC(OCC2=CC=CC=C2)=CC=C1)C3=C4C(OC(=C4)C5=CN6C(=N5)SC(OC)=N6)=CC(OC)=C3 |
| Relative Density. | 1.36 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.